🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Novavax, Inc.

NVAX Healthcare
$9.21 +$0.23 (2.56%)
Market Cap: $1.51 B
Gurus Holding
6
Popularity Rank
#1415
% of Shares Held
1.81%
Net Activity (Q1 2026)
+$22.86 M

Guru Ownership Trend

Guru Analysis for Novavax, Inc. (NVAX)

Novavax, Inc. (NVAX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $27.37 M.

Top institutional holders include Steven Cohen and Jefferies Group.

Institutional sentiment is currently Bullish. This is evidenced by a $22.86 M net inflow during the quarter.

Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Cliff Asness reduced exposure by 23.6%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q1 2026)

+$23.14 M
Total Buy Value
New Buys 4
Additions 1
-$282,262.96
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
1
Net Buyers
5

FAQs for Novavax, Inc. (NVAX)

Major holders include Steven Cohen ($12.36 M), Jefferies Group ($5.48 M), Renaissance Technologies (RenTech) ($4.05 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.97 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $22.86 M, with 5 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited NVAX. The total reported sell value was $282,262.96.

Yes, 4 managers opened new positions in NVAX, and 1 increased their existing holdings. The total reported buy value was $23.14 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.02% Add 9137.7% 1,518,211 $12.36 M Q1 2026
0.04% New Buy 673,120 $5.48 M Q1 2026
0.01% New Buy 497,383 $4.05 M Q1 2026
0.00% New Buy 128,859 $1.05 M Q1 2026
0.00% Reduce -23.6% 112,057 $912,145 Q1 2026
0.07% New Buy 42,000 $341,880 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form